Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium.

Epidermal growth factor receptor (EGFr) is expressed in human bronchial epithelial cells, and non-small cell lung cancers express increased EGFr. Squamous metaplasia of the bronchial epithelium occurs in chronic smokers and is considered an early premalignant change. In this study, EGFr expression was examined in biopsies of histologically normal and metaplastic bronchial tissues obtained from 69 smokers who were enrolled in a randomized placebo-controlled chemoprevention trial. This trial tested the effects of 6 months of treatment with 13-cis retinoic acid (13cRA) on bronchial metaplasia. EGFr expression was examined as a marker of bronchial metaplasia and response to 13cRA treatment. In bronchial biopsies obtained from patients in this study, EGFr expression was higher in metaplastic biopsies than in normal biopsies (P = 0.02). Smoking cessation during treatment correlated with reduced metaplasia (P < 0.001) and EGFr expression (P = 0.02), but multivariate analysis suggested that this effect of smoking cessation on EGFr expression was dependent upon reversal of bronchial metaplasia. 13cRA treatment did not alter EGFr expression (P = 0.23). Baseline EGFr expression levels in metaplastic biopsies did not predict metaplasia reversal. This study demonstrated that increased EGFr expression is a biomarker of bronchial metaplasia, but it did not support the hypothesis that EGFr is a biomarker of retinoid response in lung cancer chemoprevention trials.

[1]  J. E. Boers,et al.  P53 in squamous metaplasia: a marker for risk of respiratory tract carcinoma. , 1996, American journal of respiratory and critical care medicine.

[2]  S. Lam,et al.  Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. , 1995, Cancer research.

[3]  J. Minna,et al.  Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. , 1995, Journal of the National Cancer Institute.

[4]  J. Minna,et al.  Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. , 1995, JAMA.

[5]  C. Angeletti,et al.  Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype. , 1995, European journal of cancer.

[6]  S. Lippman,et al.  Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  D. Evain-Brion,et al.  Nuclear retinoic acid receptor characterization in cultured human trophoblast cells: effect of retinoic acid on epidermal growth factor receptor expression , 1994, Molecular and Cellular Endocrinology.

[8]  I. Gimenez-Conti,et al.  Altered expression of the epidermal growth factor receptor and transforming growth factor‐α during multistage skin carcinogenesis in SENCAR mice , 1994, Molecular carcinogenesis.

[9]  W. Hong,et al.  Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. , 1994, Cancer research.

[10]  K. Yoneda.  Distribution of proliferating-cell nuclear antigen and epidermal growth factor receptor in intraepithelial squamous cell lesions of human bronchus. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[11]  J. Grandis,et al.  Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. , 1993, Cancer research.

[12]  M Buyse,et al.  Adjuvant treatment of stage I lung cancer with high-dose vitamin A. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  W. Hong,et al.  Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. , 1993, Journal of the National Cancer Institute.

[14]  L. Miller,et al.  Inhibition of epidermal growth factor-like growth factor secretion in tracheobronchial epithelial cells by vitamin A. , 1993, Cancer research.

[15]  E. Dmitrovsky,et al.  Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. , 1993, Cancer research.

[16]  D. Hanahan,et al.  Betacellulin: a mitogen from pancreatic beta cell tumors. , 1993, Science.

[17]  S. Lippman,et al.  Determination of biomarkers for intermediate end points in chemoprevention trials. , 1992, Cancer research.

[18]  L. Goldsmith,et al.  Transcriptional control of epidermal growth factor receptor by retinoic acid. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[19]  R. Lotan,et al.  Suppression by retinoic acid of epidermal growth factor receptor autophosphorylation and glycosylation in cultured human head and neck squamous carcinoma cells. , 1992, Journal of the National Cancer Institute. Monographs.

[20]  M. Klagsbrun,et al.  A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF , 1991, Science.

[21]  L J Peters,et al.  Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. , 1990, The New England journal of medicine.

[22]  C. Disteche,et al.  The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity , 1990, Molecular and cellular biology.

[23]  D. Heimburger,et al.  Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. , 1988, JAMA.

[24]  J. Mendelsohn,et al.  Epidermal growth factor receptor expression in human lung carcinomas defined by a monoclonal antibody. , 1987, Journal of the National Cancer Institute.

[25]  M. Berger,et al.  Epidermal growth factor receptors in lung tumours , 1987, The Journal of pathology.

[26]  G. Gibson,et al.  Epidermal growth factor receptors in non-small cell lung cancer. , 1987, British Journal of Cancer.

[27]  P. Hasleton,et al.  Expression of epidermal growth factor receptor (EGF-R) in human lung tumours. , 1986, British Journal of Cancer.

[28]  L. King,et al.  Role of epidermal growth factor in carcinogenesis. , 1986, Cancer research.

[29]  G. Shklar,et al.  Retardation of experimental oral cancer development by retinyl acetate. , 1983, Nutrition and cancer.

[30]  J. Misset,et al.  Correlation between precancerous bronchial metaplasia and cigarette consumption, and preliminary results of retinoid treatment. , 1982, Cancer detection and prevention.

[31]  J. Schwartz,et al.  Inhibition of hamster buccal pouch carcinogenesis by 13-cis-retinoic acid. , 1980, Oral surgery, oral medicine, and oral pathology.

[32]  A. Jetten.  Retinoids specifically enhance the number of epidermal growth factor receptors , 1980, Nature.

[33]  E. C. Hammond,et al.  Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977. , 1979, The New England journal of medicine.

[34]  E. C. Hammond,et al.  Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. , 1961, The New England journal of medicine.